Anti-clastogenic effect of magnolol on benzo(a)pyrene-induced clastogenicity in mice

Food and Chemical Toxicology

Volumn 46, Issue 2, 2008, Pages 694-700

  Saito, Junichiro ^a   Shibuya, Kiyoshi ^b   Nagase, Hisamitsu ^c  

^a ASTELLAS PHARMA INC   (Japan)

^b KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Anti clastogenic effect; Antioxidative enzyme; Benzo(a)pyrene; Detoxifying enzyme; Magnolol; X ray

Indexed keywords

ACRIDINE ORANGE; BENZO[A]PYRENE; CATALASE; DNA; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; MAGNOLOL; SUPEROXIDE DISMUTASE;

AMES TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; LIVER; MALE; MICRONUCLEUS; MOUSE; MUTAGENESIS; NONHUMAN; OXIDATIVE STRESS; X IRRADIATION;

ANIMALS; BENZO(A)PYRENE; BIPHENYL COMPOUNDS; ENZYME ACTIVATION; LIGNANS; LIVER; MALE; MICE; MICE, INBRED ICR; MICRONUCLEUS TESTS; MUTAGENS;

ANIMALIA; MUS; SALMONELLA TYPHIMURIUM;

EID: 37449030716     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.09.097     Document Type: Article

References (28)

1. Bock K.W., Burchell B., Dutton G.J., Hanninen O., Mulder G.J., Owens I.S., Siest G., and Tephly T.R. UDP-glucuronosyltransferase activities: guidelines for consistent interim terminology and assay conditions. Biochem. Pharmacol. 32 (1983) 953-955
2. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
3. Durak I., Yurtarslanl Z., Canbolat O., and Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin. Chim. Acta 214 (1993) 103-104
4. Foth H., Kahl R., and Kahl G.F. Pharmacokinetics of low doses of benzo(a)pyrene in the rat. Food Chem. Toxicol. 26 (1988) 45-51
5. Fujita S., and Taira J. Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radical. Biol. Med. 17 (1994) 273-277
6. Guo Z., Smith T.J., Wang E., Sadrieh N., Ma Q., Thomas P.E., and Yang C.S. Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis 13 (1992) 2205-2210
7. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
8. Hayashi M., Morita T., Kodama Y., Sofuni T., and Ishidate Jr. M. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 245 (1990) 245-249
9. Ikeda K., and Nagase H. Magnolol has the ability to induce apoptosis in tumor cells. Biol. Pharm. Bull. 25 (2002) 1546-1549
10. Isselbacher K.J., Chrabas M.F., and Quinn R.C. The solubilization and partial purification of a glucuronyl transferase from rabbit liver microsomes. J. Biol. Chem. 237 (1962) 3033-3036
11. Kim K.B., and Lee B.M. Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo(a)pyrene. Cancer Lett. 113 (1997) 205-212
12. Kliesch U., Roupova I., and Adler I.-D. Induction of chromosome damage in mouse bone marrow by benzo(a)pyrene. Mutat. Res. 102 (1982) 265-273
13. Konoshima T., Kozuka M., Tokuda H., Nishino H., Iwashima A., Haruna M., Ito K., and Tanabe M. Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J. Nat. Prod. 54 (1991) 816-822
14. Lijinsky W. The formation and occurrence of polynuclear aromatic hydrocarbons associated with food. Mutat. Res. 259 (1991) 251-261
15. MacLeod M.C., Daylong A., Adair G., and Humphrey R.M. Differences in the rate of DNA adduct removal and the efficiency of mutagenesis for two benzo(a)pyrene diol epoxides in CHO cells. Mutat. Res. 261 (1991) 267-279
16. Mersch-Sundermann V., Mochayedi S., and Kevekordes S. Genotoxicity of polycyclic aromatic hydrocarbons in Escherichia coli PQ37. Mutat. Res. 278 (1992) 1-9
17. Moir D., Viau A., Chu I., Withey J., and McMullen E. Pharmacokinetics of benzo(a)pyrene in the rat. J. Toxicol. Environ. Health (1998) 507-530
18. Nagase H., Ikeda K., and Sakai Y. Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080 invasiveness in vitro. Planta Med. 67 (2001) 705-708
19. Pal K., Grover P.L., and Sims P. The induction of sister-chromatid exchanges in Chinese hamster ovary cells by some epoxides and phenolic derivatives of benzo(a)pyrene. Mutat. Res. 78 (1980) 193-199
20. Saito J., Sakai Y., and Nagase H. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens. Mutat. Res. 609 (2006) 68-73
21. Sporn M.B. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 36 (1976) 2699-2702
22. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34 (1988) 497-500
23. Teng C.M., Chen C.C., Ko F.N., Lee L.G., Huang T.F., Chen Y.P., and Hsu H.Y. Two antiplatelet agents from Magnolia officinalis. Thromb. Res. 50 (1988) 757-765
24. ++-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci. 47 (1990) 1153-1161
25. Tsai T.H., Chou C.J., and Chen C.F. Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection. J. Pharm. Pharmacol. 48 (1996) 57-59
26. Tsao A.S., Kim E.S., and Hong W.K. Chemoprevention of cancer. CA - Cancer J. Clin. 54 (2004) 150-180
27. Wang J.P., Ho T.F., Chang L.C., and Chen C.C. Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice,. J. Pharm. Pharmacol. 47 (1995) 857-860
28. Westerberg G., and Wiklund L. β-cyclodextrin reduces bioavailability of orally administered [3H]benzo(a)pyrene in the rat. J. Pharm. Sci. 94 (2005) 114-119